Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Molly Forrest Franke, S.D.

Co-Author

This page shows the publications co-authored by Molly Franke and Jaime Bayona.
Connection Strength

1.026
  1. Counting pyrazinamide in regimens for multidrug-resistant tuberculosis. Ann Am Thorac Soc. 2015 May; 12(5):674-9.
    View in: PubMed
    Score: 0.154
  2. Modifiable factors associated with tuberculosis disease in children: a case-control study. Pediatr Infect Dis J. 2014 Jan; 33(1):109-11.
    View in: PubMed
    Score: 0.141
  3. Parasite infection and tuberculosis disease among children: a case-control study. Am J Trop Med Hyg. 2014 Feb; 90(2):279-82.
    View in: PubMed
    Score: 0.140
  4. Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence. Clin Infect Dis. 2013 Mar; 56(6):770-6.
    View in: PubMed
    Score: 0.130
  5. Food insufficiency is a risk factor for suboptimal antiretroviral therapy adherence among HIV-infected adults in urban Peru. AIDS Behav. 2011 Oct; 15(7):1483-9.
    View in: PubMed
    Score: 0.120
  6. Validation and abbreviation of an HIV stigma scale in an adult spanish-speaking population in urban Peru. AIDS Behav. 2010 Feb; 14(1):189-99.
    View in: PubMed
    Score: 0.098
  7. Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment. Clin Infect Dis. 2008 Jun 15; 46(12):1844-51.
    View in: PubMed
    Score: 0.096
  8. Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality. PLoS One. 2013; 8(3):e58664.
    View in: PubMed
    Score: 0.033
  9. Tuberculosis in children exposed at home to multidrug-resistant tuberculosis. Pediatr Infect Dis J. 2013 Feb; 32(2):115-9.
    View in: PubMed
    Score: 0.033
  10. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study. Lancet. 2011 Jan 08; 377(9760):147-52.
    View in: PubMed
    Score: 0.028
  11. Recurrence after treatment for pulmonary multidrug-resistant tuberculosis. Clin Infect Dis. 2010 Sep 15; 51(6):709-11.
    View in: PubMed
    Score: 0.028
  12. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 2008 Aug 07; 359(6):563-74.
    View in: PubMed
    Score: 0.024
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.